profit from every €100 of sales.
€0€100
EssilorLuxottica Société anonyme
€182.35+1.36% today
-32.5% since Dec 23, 25
1-year low €139.001-year high €282.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €36.11 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What EssilorLuxottica Société anonyme sold, what it kept, and what it did with the cash.
Sales went from €24.5 billion in 2022 to €28.5 billion in 2025, with €2.32 billion of profit last year.
SalesProfit
EssilorLuxottica Société anonyme handed back 25% of the cash it generated last year.
Buybacks €376M€547M
Free cash flow 2025€3.8B
Bought back its own shares€376M
Paid as dividends€547M
Cash vs. debt€3.5B vs. €14.4B
EssilorLuxottica Société anonyme vs. similar companies
EssilorLuxottica Société anonyme grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| EssilorLuxottica Société anonyme | 36.1× · Expensive | ||
 Intuitive Surgical | 53.8× · Expensive | ||
 Becton, Dickinson and | 35.4× · Expensive | ||
 Medline | 44.8× · Expensive | ||
 HOYA | 39.3× · Expensive |
Compare EssilorLuxottica Société anonyme with Eli Lilly
AI analysis
An AI analyst reads EssilorLuxottica Société anonyme's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 24,494 | 25,395 | 26,508 | 28,491 | |
| 15,584 | 16,048 | 16,805 | 17,254 | |
| 3,156 | 3,179 | 3,447 | 3,377 | |
| 6,109 | 6,123 | 6,593 | 6,599 | |
| 2,152 | 2,289 | 2,359 | 2,315 | |
| 4.83 | 5.08 | 5.13 | 4.98 | |
| 63.6% | 63.2% | 63.4% | 60.6% | |
| 12.9% | 12.5% | 13.0% | 11.9% | |
| 8.8% | 9.0% | 8.9% | 8.1% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 60,561 | 60,523 | 64,279 | 63,895 |
| Cash | 1,960 | 2,558 | 2,251 | 3,544 |
| Total debt | 12,204 | 11,657 | 13,216 | 14,398 |
| Total liabilities | 22,414 | 21,631 | 23,277 | 24,402 |
| 37,455 | 38,239 | 40,376 | 38,889 | |
| 446 | 451 | 460 | 465 | |
| 4.8% | 4.9% | 5.0% | 4.9% | |
| 5.7% | 6.0% | 5.8% | 6.0% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 4,783 | 4,861 | 4,874 | 5,291 | |
| 1,572 | 1,531 | 1,522 | 1,525 | |
| 3,211 | 3,330 | 3,352 | 3,766 | |
| Dividends paid | 454 | 487 | 1,163 | 547 |
| 431 | 271 | 274 | 376 | |
| 191 | 195 | 162 | 280 |
Valuation
- 36.1×
- –
- 35.24
- 2.2×
- 2.9×
- 22.2×
- 14.3×
- 4.5%
- 2.8%
- 0.7%
Profitability
- 60.6%
- 11.9%
- 8.1%
- –
- 4.9%
- 4.9%
- –
- –
- –
- –
Growth
- +5.2%
- +1.0%
- –
- –
- +1.4%
Financial health
- 1.6×
- 0.37
- –
- 11.2×
- 1.10
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 47%of 952
Top 44%of 884
Bottom 35%of 601
Bottom 31%of 886
Top 25%of 987
0.7%of the share price, paid each year
On $1,000 invested$7a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
23.6% of its profit
Room to growStretchedMore than it earns: 14.5%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
44No pass
Philip Fisher
39No pass
Peter Lynch
18No pass
Joel Greenblatt
9No pass
Charlie Munger
34No pass
Terry Smith
36No pass
Questions about EssilorLuxottica Société anonyme
Is EssilorLuxottica Société anonyme a good stock to buy?
A solid business, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the EssilorLuxottica Société anonyme AI analysis
What does EssilorLuxottica Société anonyme do?
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It is in Medical Instruments & Supplies, based in Paris, France, with 155,975 employees.
Does EssilorLuxottica Société anonyme pay a dividend?
Yes. At today's price the dividend is 0.7% a year, about 24% of its yearly profit. In 2025 it paid out €547 million in dividends.
Is EssilorLuxottica Société anonyme stock halal?
Yes. EssilorLuxottica Société anonyme passes our halal screen: its business is permitted and its debt is 17% of its market value, under the 30% limit. How we check
Who are EssilorLuxottica Société anonyme's competitors?
The largest listed companies in the same industry are Intuitive Surgical, Becton, Dickinson and, Medline and HOYA. The peers table on this page compares their profit, growth and price with EssilorLuxottica Société anonyme's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.